In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Microbot Medical Inc. (NASDAQ:MBOT) reported that Bornstein Yoseph has picked up 5,305,409 of common stock as of 2016-12-08.

The acquisition brings the aggregate amount owned by Bornstein Yoseph to a total of 5,305,409 representing a 14.63% stake in the company.

For those not familiar with the company, Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. The Company’s TipCAT is an endoscope that provides and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

A glance at Microbot Medical Inc. (NASDAQ:MBOT)’s key stats reveals a current market capitalization of $13.30 million based on 1.81 million shares outstanding and a price at last close of $7.57 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-03-14, Schiffman picked up 166,000 at a purchase price of $0.30.  This brings their total holding to 1,599,717 as of the date of the filing.

On the sell side, the most recent transaction saw Stratton unload 104,549 shares at a sale price of $0.45. This brings their total holding to 556,525.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Microbot Medical Inc. (NASDAQ:MBOT) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.